Revenue (Annual) Chart

View Revenue (Annual) for CRL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 4.015B
December 31, 2024 4.050B
December 31, 2023 4.129B
December 31, 2022 3.976B
December 31, 2021 3.540B
December 31, 2020 2.924B
December 31, 2019 2.621B
December 31, 2018 2.266B
December 31, 2017 1.858B
December 31, 2016 1.681B
December 31, 2015 1.363B
December 31, 2014 1.298B
December 31, 2013 1.166B
December 31, 2012 1.130B
December 31, 2011 1.143B
Date Value
December 31, 2010 1.133B
December 31, 2009 1.203B
December 31, 2008 1.343B
December 31, 2007 1.231B
December 31, 2006 1.058B
December 31, 2005 993.33M
December 31, 2004 766.92M
December 31, 2003 613.72M
December 31, 2002 554.63M
December 31, 2001 465.63M
December 31, 2000 306.58M
December 31, 1999 272.56M
December 31, 1998 193.30M
December 31, 1997 170.71M
December 31, 1996 155.60M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
IQVIA Holdings, Inc. 16.30B
Medpace Holdings, Inc. 2.530B
Fortrea Holdings, Inc. 2.723B
Avantor, Inc. 6.552B
Champions Oncology, Inc. 59.42M